Leo Grady, the former CEO of Paige AI – developers of the first AI-based histology software to be granted approval by the US Food and Drug Administration – has turned his attention to the gut health space.
Leo Grady’s Jona Hopes To Repair Microbiome Testing’s Murky Reputation
After leading Paige to success with the FDA, Grady has turned his attention to the microbiome. He hopes his new company, Jona, will be able to provide detailed insights to doctors, their patients and pharmaceutical players.
